Literature DB >> 27151536

LSD-induced entropic brain activity predicts subsequent personality change.

A V Lebedev1, M Kaelen2, M Lövdén1, J Nilsson1, A Feilding3, D J Nutt2, R L Carhart-Harris2.   

Abstract

Personality is known to be relatively stable throughout adulthood. Nevertheless, it has been shown that major life events with high personal significance, including experiences engendered by psychedelic drugs, can have an enduring impact on some core facets of personality. In the present, balanced-order, placebo-controlled study, we investigated biological predictors of post-lysergic acid diethylamide (LSD) changes in personality. Nineteen healthy adults underwent resting state functional MRI scans under LSD (75µg, I.V.) and placebo (saline I.V.). The Revised NEO Personality Inventory (NEO-PI-R) was completed at screening and 2 weeks after LSD/placebo. Scanning sessions consisted of three 7.5-min eyes-closed resting-state scans, one of which involved music listening. A standardized preprocessing pipeline was used to extract measures of sample entropy, which characterizes the predictability of an fMRI time-series. Mixed-effects models were used to evaluate drug-induced shifts in brain entropy and their relationship with the observed increases in the personality trait openness at the 2-week follow-up. Overall, LSD had a pronounced global effect on brain entropy, increasing it in both sensory and hierarchically higher networks across multiple time scales. These shifts predicted enduring increases in trait openness. Moreover, the predictive power of the entropy increases was greatest for the music-listening scans and when "ego-dissolution" was reported during the acute experience. These results shed new light on how LSD-induced shifts in brain dynamics and concomitant subjective experience can be predictive of lasting changes in personality. Hum Brain Mapp 37:3203-3213, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  LSD-25; entropy; neuroplasticity; personality; transpersonal experience

Mesh:

Substances:

Year:  2016        PMID: 27151536      PMCID: PMC6867426          DOI: 10.1002/hbm.23234

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  58 in total

1.  Physiological time-series analysis using approximate entropy and sample entropy.

Authors:  J S Richman; J R Moorman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-06       Impact factor: 4.733

2.  Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.

Authors:  Peter S Hendricks; Christopher B Thorne; C Brendan Clark; David W Coombs; Matthew W Johnson
Journal:  J Psychopharmacol       Date:  2015-01-13       Impact factor: 4.153

3.  Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada.

Authors:  Gerald Thomas; Philippe Lucas; N Rielle Capler; Kenneth W Tupper; Gina Martin
Journal:  Curr Drug Abuse Rev       Date:  2013-03

4.  Negative and positive life events are associated with small but lasting change in neuroticism.

Authors:  B F Jeronimus; J Ormel; A Aleman; B W J H Penninx; H Riese
Journal:  Psychol Med       Date:  2013-02-15       Impact factor: 7.723

5.  Personality in adulthood: a six-year longitudinal study of self-reports and spouse ratings on the NEO Personality Inventory.

Authors:  P T Costa; R R McCrae
Journal:  J Pers Soc Psychol       Date:  1988-05

6.  Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.

Authors:  Rr Griffiths; Wa Richards; Mw Johnson; Ud McCann; R Jesse
Journal:  J Psychopharmacol       Date:  2008-07-01       Impact factor: 4.153

7.  An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data.

Authors:  Theodore D Satterthwaite; Mark A Elliott; Raphael T Gerraty; Kosha Ruparel; James Loughead; Monica E Calkins; Simon B Eickhoff; Hakon Hakonarson; Ruben C Gur; Raquel E Gur; Daniel H Wolf
Journal:  Neuroimage       Date:  2012-08-25       Impact factor: 6.556

8.  Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.

Authors:  Matthew W Johnson; Albert Garcia-Romeu; Mary P Cosimano; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2014-09-11       Impact factor: 4.153

9.  d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex.

Authors:  Chad J Reissig; Richard A Rabin; Jerrold C Winter; Cynthia A Dlugos
Journal:  Eur J Pharmacol       Date:  2008-01-07       Impact factor: 4.432

10.  Neural correlates of the LSD experience revealed by multimodal neuroimaging.

Authors:  Robin L Carhart-Harris; Suresh Muthukumaraswamy; Leor Roseman; Mendel Kaelen; Wouter Droog; Kevin Murphy; Enzo Tagliazucchi; Eduardo E Schenberg; Timothy Nest; Csaba Orban; Robert Leech; Luke T Williams; Tim M Williams; Mark Bolstridge; Ben Sessa; John McGonigle; Martin I Sereno; David Nichols; Peter J Hellyer; Peter Hobden; John Evans; Krish D Singh; Richard G Wise; H Valerie Curran; Amanda Feilding; David J Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 12.779

View more
  52 in total

Review 1.  REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.

Authors:  R L Carhart-Harris; K J Friston
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  How ecstasy and psilocybin are shaking up psychiatry.

Authors:  Paul Tullis
Journal:  Nature       Date:  2021-01       Impact factor: 49.962

3.  The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.

Authors:  Frederick S Barrett; Matthew P Bradstreet; Jeannie-Marie S Leoutsakos; Matthew W Johnson; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2016-11-17       Impact factor: 4.153

4.  Neuroticism is associated with challenging experiences with psilocybin mushrooms.

Authors:  Frederick S Barrett; Matthew W Johnson; Roland R Griffiths
Journal:  Pers Individ Dif       Date:  2017-06-07

5.  Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review.

Authors:  Kristóf János Bodnár; Péter Kakuk
Journal:  Med Health Care Philos       Date:  2019-06

6.  Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.

Authors:  Patrick C Dolder; Matthias E Liechti; Katharina M Rentsch
Journal:  J Clin Lab Anal       Date:  2017-05-26       Impact factor: 2.352

7.  A Five-Factor Theory Perspective on Causal Analysis.

Authors:  Robert R McCrae; Angelina R Sutin
Journal:  Eur J Pers       Date:  2018-01-15

8.  Psychedelics, Meditation, and Self-Consciousness.

Authors:  Raphaël Millière; Robin L Carhart-Harris; Leor Roseman; Fynn-Mathis Trautwein; Aviva Berkovich-Ohana
Journal:  Front Psychol       Date:  2018-09-04

9.  Diffusion Entropy: A Potential Neuroimaging Biomarker of Bipolar Disorder in the Temporal Pole.

Authors:  Karl Spuhler; Elizabeth Bartlett; Jie Ding; Christine DeLorenzo; Ramin Parsey; Chuan Huang
Journal:  Synapse       Date:  2017-10-07       Impact factor: 2.562

Review 10.  Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice.

Authors:  Jake E Payne; Richard Chambers; Paul Liknaitzky
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.